What is the current valuation of the Esophageal Dysphagia Market as of 2024?

The Esophageal Dysphagia Market was valued at 2.02 USD Billion in 2024. Read More

What is the projected market size for the Esophageal Dysphagia Market in 2035?

The market is projected to reach 3.603 USD Billion by 2035. Read More

What is the expected CAGR for the Esophageal Dysphagia Market during the forecast period 2025 - 2035?

The expected CAGR for the Esophageal Dysphagia Market during 2025 - 2035 is 5.4%. Read More

Which companies are considered key players in the Esophageal Dysphagia Market?

Key players include Medtronic, Boston Scientific, Johnson & Johnson, and Abbott Laboratories. Read More

What segment of the Esophageal Dysphagia Market had the highest valuation in 2024?

The Diagnosis segment, particularly Endoscopy, had the highest valuation at 0.4 USD Billion in 2024. Read More

How does the Treatment segment's valuation compare to the Diagnosis segment in 2024?

The Treatment segment was valued at 0.5 USD Billion, slightly lower than the Diagnosis segment's 0.4 USD Billion in 2024. Read More

What are the projected values for the Feeding Tubes product segment by 2035?

The Feeding Tubes segment is projected to reach between 0.25 and 0.45 USD Billion by 2035. Read More

Which end-user segment is expected to dominate the Esophageal Dysphagia Market by 2035?

Hospitals and Clinics are expected to dominate, with a projected valuation of 1.45 USD Billion by 2035. Read More

What is the anticipated growth trend for the Esophageal Dysphagia Market in the coming years?

The market is anticipated to grow steadily, driven by advancements in treatment and diagnostic technologies. Read More

How do lifestyle changes factor into the Treatment segment's valuation?

Lifestyle Changes are projected to contribute between 0.12 and 0.2 USD Billion to the Treatment segment by 2035. Read More

Esophageal Dysphagia Market

Esophageal Dysphagia Market Research Report Information By Diagnosis (Dynamic Swallowing Study, X-ray, Endoscopy, Manometry, Imaging scans, MRI scan, and CT scan), By Treatment (Esophageal Dilation, Surgery, Stent Placement, Laparoscopic Heller Myotomy, Medications, and Lifestyle Changes), By Products (Feeding Tube, Nasogastric Tube, Percutaneous Endoscopic Gastrostomy, Nutritional Solutions, Thickeners, Beverages, Purees, Drugs, Proton Pump Inhibitors, and Other), & End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Research Centers, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Forecast Period

2025 - 2035

CAGR

5.4%

2024 Market Size

$ 2.02 Billion

2035 Market Size

$ 3.6 Billion

Medical Device ● Updated April 2026 Report ID: MRFR/MED/5002-HCR | Pages: 90 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Diagnosis (USD Billion)
  1. 4.1.1 Dynamic Swallowing Study
  2. 4.1.2 X-ray
  3. 4.1.3 Endoscopy
  4. 4.1.4 Manometry
  5. 4.1.5 Imaging scans
  6. 4.1.6 MRI scan
  7. 4.1.7 CT scan
2. 4.2 Healthcare, BY Treatment (USD Billion)
  1. 4.2.1 Esophageal Dilation
  2. 4.2.2 Surgery
  3. 4.2.3 Stent placement
  4. 4.2.4 Laparoscopic Heller Myotomy
  5. 4.2.5 Medications
  6. 4.2.6 Lifestyle Changes
3. 4.3 Healthcare, BY Product (USD Billion)
  1. 4.3.1 Feeding Tubes
  2. 4.3.2 Nasogastric Tubes
  3. 4.3.3 Percutaneous Endoscopic Gastrostomy
  4. 4.3.4 Nutritional Solutions
  5. 4.3.5 Thickeners
  6. 4.3.6 Beverages
  7. 4.3.7 Purees
  8. 4.3.8 Drugs
  9. 4.3.9 Proton Pump Inhibitors
  10. 4.3.10 Others
4. 4.4 Healthcare, BY End-User (USD Billion)
  1. 4.4.1 Hospitals and Clinics
  2. 4.4.2 Ambulatory Surgical Centers
  3. 4.4.3 Diagnostic Centers
  4. 4.4.4 Research Centers
  5. 4.4.5 Others
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Abbott Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cook Medical (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Olympus Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Conmed Corporation (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Stryker Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 B. Braun Melsungen AG (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY DIAGNOSIS
4. 6.4 US MARKET ANALYSIS BY TREATMENT
5. 6.5 US MARKET ANALYSIS BY PRODUCT
6. 6.6 US MARKET ANALYSIS BY END-USER
7. 6.7 CANADA MARKET ANALYSIS BY DIAGNOSIS
8. 6.8 CANADA MARKET ANALYSIS BY TREATMENT
9. 6.9 CANADA MARKET ANALYSIS BY PRODUCT
10. 6.10 CANADA MARKET ANALYSIS BY END-USER
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY DIAGNOSIS
13. 6.13 GERMANY MARKET ANALYSIS BY TREATMENT
14. 6.14 GERMANY MARKET ANALYSIS BY PRODUCT
15. 6.15 GERMANY MARKET ANALYSIS BY END-USER
16. 6.16 UK MARKET ANALYSIS BY DIAGNOSIS
17. 6.17 UK MARKET ANALYSIS BY TREATMENT
18. 6.18 UK MARKET ANALYSIS BY PRODUCT
19. 6.19 UK MARKET ANALYSIS BY END-USER
20. 6.20 FRANCE MARKET ANALYSIS BY DIAGNOSIS
21. 6.21 FRANCE MARKET ANALYSIS BY TREATMENT
22. 6.22 FRANCE MARKET ANALYSIS BY PRODUCT
23. 6.23 FRANCE MARKET ANALYSIS BY END-USER
24. 6.24 RUSSIA MARKET ANALYSIS BY DIAGNOSIS
25. 6.25 RUSSIA MARKET ANALYSIS BY TREATMENT
26. 6.26 RUSSIA MARKET ANALYSIS BY PRODUCT
27. 6.27 RUSSIA MARKET ANALYSIS BY END-USER
28. 6.28 ITALY MARKET ANALYSIS BY DIAGNOSIS
29. 6.29 ITALY MARKET ANALYSIS BY TREATMENT
30. 6.30 ITALY MARKET ANALYSIS BY PRODUCT
31. 6.31 ITALY MARKET ANALYSIS BY END-USER
32. 6.32 SPAIN MARKET ANALYSIS BY DIAGNOSIS
33. 6.33 SPAIN MARKET ANALYSIS BY TREATMENT
34. 6.34 SPAIN MARKET ANALYSIS BY PRODUCT
35. 6.35 SPAIN MARKET ANALYSIS BY END-USER
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY DIAGNOSIS
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY TREATMENT
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY PRODUCT
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USER
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY DIAGNOSIS
42. 6.42 CHINA MARKET ANALYSIS BY TREATMENT
43. 6.43 CHINA MARKET ANALYSIS BY PRODUCT
44. 6.44 CHINA MARKET ANALYSIS BY END-USER
45. 6.45 INDIA MARKET ANALYSIS BY DIAGNOSIS
46. 6.46 INDIA MARKET ANALYSIS BY TREATMENT
47. 6.47 INDIA MARKET ANALYSIS BY PRODUCT
48. 6.48 INDIA MARKET ANALYSIS BY END-USER
49. 6.49 JAPAN MARKET ANALYSIS BY DIAGNOSIS
50. 6.50 JAPAN MARKET ANALYSIS BY TREATMENT
51. 6.51 JAPAN MARKET ANALYSIS BY PRODUCT
52. 6.52 JAPAN MARKET ANALYSIS BY END-USER
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY DIAGNOSIS
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY TREATMENT
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY PRODUCT
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USER
57. 6.57 MALAYSIA MARKET ANALYSIS BY DIAGNOSIS
58. 6.58 MALAYSIA MARKET ANALYSIS BY TREATMENT
59. 6.59 MALAYSIA MARKET ANALYSIS BY PRODUCT
60. 6.60 MALAYSIA MARKET ANALYSIS BY END-USER
61. 6.61 THAILAND MARKET ANALYSIS BY DIAGNOSIS
62. 6.62 THAILAND MARKET ANALYSIS BY TREATMENT
63. 6.63 THAILAND MARKET ANALYSIS BY PRODUCT
64. 6.64 THAILAND MARKET ANALYSIS BY END-USER
65. 6.65 INDONESIA MARKET ANALYSIS BY DIAGNOSIS
66. 6.66 INDONESIA MARKET ANALYSIS BY TREATMENT
67. 6.67 INDONESIA MARKET ANALYSIS BY PRODUCT
68. 6.68 INDONESIA MARKET ANALYSIS BY END-USER
69. 6.69 REST OF APAC MARKET ANALYSIS BY DIAGNOSIS
70. 6.70 REST OF APAC MARKET ANALYSIS BY TREATMENT
71. 6.71 REST OF APAC MARKET ANALYSIS BY PRODUCT
72. 6.72 REST OF APAC MARKET ANALYSIS BY END-USER
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY DIAGNOSIS
75. 6.75 BRAZIL MARKET ANALYSIS BY TREATMENT
76. 6.76 BRAZIL MARKET ANALYSIS BY PRODUCT
77. 6.77 BRAZIL MARKET ANALYSIS BY END-USER
78. 6.78 MEXICO MARKET ANALYSIS BY DIAGNOSIS
79. 6.79 MEXICO MARKET ANALYSIS BY TREATMENT
80. 6.80 MEXICO MARKET ANALYSIS BY PRODUCT
81. 6.81 MEXICO MARKET ANALYSIS BY END-USER
82. 6.82 ARGENTINA MARKET ANALYSIS BY DIAGNOSIS
83. 6.83 ARGENTINA MARKET ANALYSIS BY TREATMENT
84. 6.84 ARGENTINA MARKET ANALYSIS BY PRODUCT
85. 6.85 ARGENTINA MARKET ANALYSIS BY END-USER
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY DIAGNOSIS
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TREATMENT
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY DIAGNOSIS
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TREATMENT
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USER
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY DIAGNOSIS
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TREATMENT
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USER
99. 6.99 REST OF MEA MARKET ANALYSIS BY DIAGNOSIS
100. 6.100 REST OF MEA MARKET ANALYSIS BY TREATMENT
101. 6.101 REST OF MEA MARKET ANALYSIS BY PRODUCT
102. 6.102 REST OF MEA MARKET ANALYSIS BY END-USER
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY DIAGNOSIS, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY DIAGNOSIS, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY TREATMENT, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY TREATMENT, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY END-USER, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.2.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.2.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.3.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.3.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.3.4 BY END-USER, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.4.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.4.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.4.4 BY END-USER, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.5.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.5.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.5.4 BY END-USER, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.6.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.6.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.6.4 BY END-USER, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.7.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.7.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.7.4 BY END-USER, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.8.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.8.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.8.4 BY END-USER, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.9.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.9.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.9.4 BY END-USER, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.10.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.10.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.10.4 BY END-USER, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.11.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.11.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.11.4 BY END-USER, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.12.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.12.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.12.4 BY END-USER, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.13.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.13.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.13.4 BY END-USER, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.14.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.14.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.14.4 BY END-USER, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.15.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.15.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.15.4 BY END-USER, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.16.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.16.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.16.4 BY END-USER, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.17.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.17.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.17.4 BY END-USER, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.18.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.18.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.18.4 BY END-USER, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.19.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.19.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.19.4 BY END-USER, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.20.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.20.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.20.4 BY END-USER, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.21.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.21.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.21.4 BY END-USER, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.22.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.22.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.22.4 BY END-USER, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.23.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.23.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.23.4 BY END-USER, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.24.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.24.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.24.4 BY END-USER, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.25.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.25.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.25.4 BY END-USER, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.26.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.26.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.26.4 BY END-USER, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.27.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.27.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.27.4 BY END-USER, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.28.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.28.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.28.4 BY END-USER, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.29.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.29.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.29.4 BY END-USER, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY DIAGNOSIS, 2025-2035 (USD Billion)
  2. 7.30.2 BY TREATMENT, 2025-2035 (USD Billion)
  3. 7.30.3 BY PRODUCT, 2025-2035 (USD Billion)
  4. 7.30.4 BY END-USER, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Esophageal Dysphagia Market Segmentation

Esophageal Dysphagia Market By Diagnosis (USD Billion, 2025-2035)

Dynamic Swallowing Study
X-ray
Endoscopy
Manometry
Imaging scans
MRI scan
CT scan

Esophageal Dysphagia Market By Treatment (USD Billion, 2025-2035)

Esophageal Dilation
Surgery
Stent placement
Laparoscopic Heller Myotomy
Medications
Lifestyle Changes

Esophageal Dysphagia Market By Product (USD Billion, 2025-2035)

Feeding Tubes
Nasogastric Tubes
Percutaneous Endoscopic Gastrostomy
Nutritional Solutions
Thickeners
Beverages
Purees
Drugs
Proton Pump Inhibitors
Others

Esophageal Dysphagia Market By End-User (USD Billion, 2025-2035)

Hospitals and Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Research Centers
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”